203 related articles for article (PubMed ID: 28482784)
1. Recent Advancemnts in Biodegradable Ocular Implants.
Mittal S; Miranda O
Curr Drug Deliv; 2018 Feb; 15(2):144-154. PubMed ID: 28482784
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable implants for sustained drug release in the eye.
Lee SS; Hughes P; Ross AD; Robinson MR
Pharm Res; 2010 Oct; 27(10):2043-53. PubMed ID: 20535532
[TBL] [Abstract][Full Text] [Related]
3. Preparation of dexamethasone ophthalmic implants: a comparative study of in vitro release profiles.
Prata AI; Coimbra P; Pina ME
Pharm Dev Technol; 2018 Mar; 23(3):218-224. PubMed ID: 28300463
[TBL] [Abstract][Full Text] [Related]
4. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
6. In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.
Yavuz B; Bozdağ Pehlivan S; Kaffashi A; Çalamak S; Ulubayram K; Palaska E; Çakmak HB; Ünlü N
Drug Deliv; 2016 Nov; 23(9):3279-3284. PubMed ID: 27027148
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review on the Role of Polymers in Ocular Drug Delivery.
Paramjot ; Wadhwa S; Sharma A; Singh SK; Vishwas S; Kumar R; Singh S; Dua K; Chellappan DK; Gupta G
Curr Drug Deliv; 2024; 21(1):16-37. PubMed ID: 36627785
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review.
Osi B; Khoder M; Al-Kinani AA; Alany RG
Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285
[TBL] [Abstract][Full Text] [Related]
11. Ocular delivery of macromolecules.
Kim YC; Chiang B; Wu X; Prausnitz MR
J Control Release; 2014 Sep; 190():172-81. PubMed ID: 24998941
[TBL] [Abstract][Full Text] [Related]
12. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
13. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
15. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.
Subrizi A; Del Amo EM; Korzhikov-Vlakh V; Tennikova T; Ruponen M; Urtti A
Drug Discov Today; 2019 Aug; 24(8):1446-1457. PubMed ID: 30738982
[TBL] [Abstract][Full Text] [Related]
16. Novel prospective in colon specific drug delivery system.
Bansal V; Malviya R; Malaviya T; Sharma PK
Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
18. Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.
Shen HH; Chan EC; Lee JH; Bee YS; Lin TW; Dusting GJ; Liu GS
Nanomedicine (Lond); 2015; 10(13):2093-107. PubMed ID: 26096379
[TBL] [Abstract][Full Text] [Related]
19. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
Sah AK; Suresh PK
Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
